Nisa Investment Advisors
IONS icon

Nisa Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Nisa Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
580
+579
+57,900% +$43.6K ﹤0.01% 1891
2026
Q1 		$75 Hold
1
– – ﹤0.01% 3016
2025
Q4 		$79 Buy
+1
New +$75 ﹤0.01% 2939
2022
Q3 		– Sell
-359
Closed -$13K – 2611
2022
Q2 		$13K Hold
359
– – ﹤0.01% 2144
2022
Q1 		$13K Hold
359
– – ﹤0.01% 2152
2021
Q4 		$11K Sell
359
-5,890
-94% -$185K ﹤0.01% 2016
2021
Q3 		$210K Sell
6,249
-1,534
-20% -$57.8K ﹤0.01% 1389
2021
Q2 		$310K Sell
7,783
-42,042
-84% -$1.65M ﹤0.01% 1269
2021
Q1 		$2.24M Buy
49,825
+7,462
+18% +$416K 0.01% 679
2020
Q4 		$2.4M Buy
42,363
+30,691
+263% +$1.53M 0.02% 642
2020
Q3 		$554K Sell
11,672
-23,605
-67% -$1.31M ﹤0.01% 1014
2020
Q2 		$2.08M Buy
35,277
+25,556
+263% +$1.42M 0.02% 578
2020
Q1 		$460K Buy
9,721
+3,075
+46% +$171K 0.01% 948
2019
Q4 		$401K Buy
6,646
+1,231
+23% +$73.3K ﹤0.01% 1158
2019
Q3 		$324K Sell
5,415
-23,949
-82% -$1.56M ﹤0.01% 1212
2019
Q2 		$1.89M Buy
29,364
+21,688
+283% +$1.53M 0.02% 655
2019
Q1 		$623K Buy
7,676
+317
+4% +$20.4K 0.01% 984
2018
Q4 		$398K Hold
7,359
– – ﹤0.01% 1065
2018
Q3 		$380K Buy
+7,359
New +$346K ﹤0.01% 1168
2017
Q1 		– Sell
-600
Closed -$29K – 1883
2016
Q4 		$29K Sell
600
-700
-54% -$27.7K ﹤0.01% 1525
2016
Q3 		$48K Hold
1,300
– – ﹤0.01% 1408
2016
Q2 		$30K Hold
1,300
– – ﹤0.01% 1482
2016
Q1 		$53K Buy
+1,300
New +$52.8K ﹤0.01% 1389

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nisa Investment Advisors's IONS Position: Q2 2026 in Review

Nisa Investment Advisors increased its Ionis Pharmaceuticals (IONS) stake by 57,900% in Q2 2026, buying an estimated $43.6K and bringing the position to 580 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Nisa Investment Advisors first reported a position in IONS in Q1 2016 and has held it in 23 quarters since. The position peaked at $2.4M in Q4 2020. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Nisa Investment Advisors held 580 shares of Ionis Pharmaceuticals worth $46K as of Q2 2026.
  • Nisa Investment Advisors bought 579 Ionis Pharmaceuticals shares in Q2 2026, an estimated $43.6K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1891 holding.
  • Nisa Investment Advisors first reported a position in Ionis Pharmaceuticals in Q1 2016 and has held it in 23 quarters since.
  • Nisa Investment Advisors's Ionis Pharmaceuticals position peaked at $2.4M in Q4 2020.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.